The role of Pin1 in mediating ATO’s anticancer activity is further supported by the findings that human breast cancer cells were differentially susceptible to ATO and highly correlated with the rate of ATO-induced Pin1 degradation and with the expression of the ATO transporter AQP9. The gene discussed is PIN1; the disease is breast carcinoma.